Equities

GemPharmatech Co Ltd

688046:SHH

GemPharmatech Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)11.11
  • Today's Change-0.12 / -1.07%
  • Shares traded1.63m
  • 1 Year change-36.22%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,3181,213499
Total Receivables, Net288201172
Total Inventory474930
Prepaid expenses4.293.115.37
Other current assets, total0.60----
Total current assets1,6581,467707
Property, plant & equipment, net629395238
Goodwill, net------
Intangibles, net474950
Long term investments1766930
Note receivable - long term------
Other long term assets0238--
Total assets2,5782,2541,054
LIABILITIES
Accounts payable1025162
Accrued expenses454334
Notes payable/short-term debt76125.15
Current portion long-term debt/capital leases9.402.61--
Other current liabilities, total13410590
Total current liabilities366214192
Total long term debt363.0520
Total debt1221825
Deferred income tax9.419.906.50
Minority interest------
Other liabilities, total414950
Total liabilities453276269
SHAREHOLDERS EQUITY
Common stock410410360
Additional paid-in capital1,2581,254277
Retained earnings (accumulated deficit)455313149
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1.090.910.27
Total equity2,1251,978786
Total liabilities & shareholders' equity2,5782,2541,054
Total common shares outstanding410410410
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.